Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06457503
What this trial is testing

Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer Recurrent
Coherus Oncology, Inc. 100
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Testing effectiveness (Phase 2)Study completedNCT00507767
What this trial is testing

Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more
National Cancer Institute (NCI) 15
Not applicableStudy completedNCT03314051
What this trial is testing

Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA

Who this might be right for
Nasopharyngeal CarcinomaEBV Related Carcinoma
Taichung Veterans General Hospital 366
Not applicableStudy completedNCT04387266
What this trial is testing

To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 471
Testing effectiveness (Phase 2)Study completedNCT00052429
What this trial is testing

High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00002922
What this trial is testing

Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04605562
What this trial is testing

Umbrella Biomarker-Guided Therapy in NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 206
Large-scale testing (Phase 3)Looking for participantsNCT07154069
What this trial is testing

Adaptive Immunotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 802
Large-scale testing (Phase 3)Not Yet RecruitingNCT04890522
What this trial is testing

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

Who this might be right for
Nasopharyngeal CarcinomaMetastasisChemotherapy+2 more
Sun Yat-sen University 622
Testing effectiveness (Phase 2)Study completedNCT05563480
What this trial is testing

TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT05340270
What this trial is testing

PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoadjuvant TherapyPD-1 Inhibitor
Guangxi Medical University 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06987123
What this trial is testing

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 62
Testing effectiveness (Phase 2)Study completedNCT00188877
What this trial is testing

Intensity Modulated Radiation Therapy for Head and Neck Cancer

Who this might be right for
Nasopharyngeal Neoplasms
University Health Network, Toronto 44
Not applicableUnknownNCT06032767
What this trial is testing

Prospective Observational Study to Predict Severe Oral Mucositis Associated With Chemoradiotherapy in Nasopharyngeal Carcinoma Based on Deep Learning

Who this might be right for
Nasopharyngeal CarcinomaOral Mucositis
Sun Yat-sen University 480
Testing effectiveness (Phase 2)UnknownNCT03290820
What this trial is testing

Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 184
Large-scale testing (Phase 3)Not Yet RecruitingNCT07072000
What this trial is testing

Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Hai-Qiang Mai,MD,PhD 550
Large-scale testing (Phase 3)Ended earlyNCT02363400
What this trial is testing

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

Who this might be right for
Nasopharyngeal Carcinoma
National Health Research Institutes, Taiwan 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04925544
What this trial is testing

Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

Who this might be right for
Nasopharyngeal CancerEpstein-Barr Virus Related Carcinoma
Stanford University 13
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06688175
What this trial is testing

IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal NeoplasmsElderlyChemotherapy
The First Affiliated Hospital of Xiamen University 32
Next Page